Ann: FY21 Results Presentation, page-5

The outlook as per usual is not quantified, which is what you expect from this company because they simply wouldn't know. It makes it difficult to be optimistic about this company when everything has been in retreat for a long time. That $11m+ B2B month (April 2020) seems like it was a lifetime ago. One of my bigger regrets is that I have waited for the turn around far too long instead of just getting out. No doubt some investors will pin their hopes on animal health, but how much longer do you wait for anything substantial to happen on that front?